Roquette, a company involved in plant-based ingredients and pharmaceutical excipients, has completed the acquisition of Qualicaps, the third largest producer of hard capsules for oral dosage solutions. The combination of the two businesses contributes to Roquette’s strategic growth plan and will create new opportunities for Roquette and Qualicaps’ customers and employees.
 
Qualicaps, headquartered in Nara, Japan, has a client base that includes major pharmaceutical and food companies around the world, and a workforce of 1,400 employees located in sites in Asia, Europe, and the Americas.
 
The strategic investment expands the global footprint of Roquette’s pharmaceutical business, as well as its offerings of oral dosage solutions. Qualicaps adds expertise in capsules, as well as its assets and infrastructure. The newly combined businesses will offer a comprehensive range of diverse oral dosage solutions to existing and new customers.
 
Qualicaps’ global footprint, with manufacturing and R&D sites in Japan, Spain, Romania, Canada, the U.S., and Brazil, will allow Roquette to expand its presence and be closer to its customers and markets.

Pierre Courduroux, CEO of Roquette, said, “This acquisition is a key milestone in our journey to reinforce our global leadership in pharmaceutical solutions, and to consolidate our position in nutrition and health markets. Thanks to our combined workforce, we will continue to grow our business through collaboration with our customers, and to bring our expertise and innovation to all stages of pharmaceutical development.”
 
Seiichiro Matsumura, CEO of Qualicaps, said, “Today marks a pivotal moment in Qualicaps’ journey. Partnering with Roquette, a renowned global leader in pharmaceutical excipients, marks the beginning of a transformative era of growth and innovation for our company. Together, we are poised to lead innovation, enrich our product portfolio, and deliver greater value to our global customer and stakeholder base. This partnership is an important step forward in our commitment to advancing healthcare solutions worldwide.”